Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
SK Biopharmaceuticals Announces 100,000 Patients Globally Have Been Treated with Cenobamate Through Sales of XCOPRI® and ONTOZRY® in the U.S., Europe, Israel, and Canada 2024-03-12 08:00
Cell Impact has received an order worth SEK 18 million in the field of electrolysis 2024-03-12 06:48
Appointment of Dr Darren Patti to Group Chief Operating Officer 2024-03-12 05:44
Mabwell to Present ADC Platform IDDC™ and the Latest Study Results of Multiple Novel ADCs at the 14th World ADC London 2024-03-11 22:00
Medicilon has appointed Dr. Qingcong Lin as President of Medicilon USA Corp., further deepening the global strategic layout 2024-03-11 20:30
ONO Enters into a University-Wide, Research Alliance Agreement with Harvard University 2024-03-11 20:00
TiumBio to Initiate Phase 2 Trial of TU2218 for Cancer 2024-03-11 20:00
ImmunAbs Announces Conclusion of Phase 1 Clinical Trial, Revealing Positive Topline Results 2024-03-11 17:00
Upcoming 89th CMEF in Shanghai to Showcase Innovative Technological Advancements Spanning the Entire Value Chain of the Medical Equipment Industry 2024-03-11 15:20
AI Empowers Surgery: CAIR unveils its latest large multimodality model for surgery 2024-03-11 15:06
Apollo Hospitals Unveils South Asia's First ZAP-X, Transforming Brain Tumor Care 2024-03-11 15:00
Fullerton Health Deepens Commitment to Community Health with Health Hub Clinics in the Heartlands 2024-03-11 14:00
RemeGen Presents Oral Presentation on Evaluation of Its Proprietary Disitamab Vedotin (RC48) for Cervical Cancer at ESGO 2024 2024-03-11 10:36
APPIS 2024: Healthcare Stakeholders Come Together to Prioritize Action for Better Patient Outcomes in Asia Pacific, Middle East, and Africa 2024-03-11 10:00
Everest Medicines Announces Acceptance of VELSIPITY® New Drug Application in Macau 2024-03-11 09:00
Ascletis Announces Poster Presentation of Phase II Study Final Results of FASN Inhibitor ASC40 for Treatment of Acne at 2024 AAD Annual Meeting 2024-03-11 08:10
Launch of CMDF Showcase Event to Share Achievements, Promote Chinese Medicine Culture to Public and Remark a New Mileage of Chinese Medicine Development 2024-03-09 18:17
Regor Initiates Phase 2 Study of Oral Once-daily GLP-1 Agonist RGT-075 for the Treatment of Obesity 2024-03-08 23:24
Additional COBRA results: SAR-bisPSMA detects lesions in the 2-millimetre range 2024-03-08 22:02
Mabwell to Present the Clinical Data of 9MW2821 in Cervical Cancer as Focused Plenary Oral Presentation at 2024 Society of Gynecologic Oncology Annual Meeting on Women's Cancer 2024-03-08 22:00
1 88 89 90 91 92 962